Managing atopic dermatitis goes beyond treating primary symptoms such as itch and scaling. In a Next Steps in Derm video interview conducted in conjunction with the Pigmentary Disorders Exchange Symposium, Andrew F. Alexis, MD, MPH, FAAD, focuses on the complexities and solutions involved in addressing both the inflammatory aspects and associated pigmentary changes.

‍

Dr. Alexis, professor of clinical dermatology and vice-chair for diversity and inclusion at Weill Cornell Medicine, highlights the common scenario where patients seek intervention for pigmentary changes without realizing their connection to atopic dermatitis. The primary step, as he suggests, is educating patients about the link while formulating a comprehensive treatment plan that targets the underlying inflammatory disorder.

‍

When considering treatments, Dr. Alexis advocates for the cautious use of skin lightening agents. He outlines ingredients that can be incorporated into the treatment of persistent hyperpigmentation, post-clearance of eczema patches, while being mindful of the irritation risk.

‍

Dr. Alexis’s insights into the nuanced management of atopic dermatitis and its pigmentary consequences underscore a blend of patient education, strategic treatment, and cautious use of cosmeceuticals in fostering better dermatological outcomes.